TY  - GEN
AU  - Blonde,L
AU  - Klein,E J
AU  - Han,J
AU  - Zhang,B
AU  - Mac,S M
AU  - Poon,T H
AU  - Taylor,K L
AU  - Trautmann,M E
AU  - Kim,D D
AU  - Kendall,D M
TI  - Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes
SN  - 1462-8902
PY  - 2007///0329
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Blood Glucose
KW  - metabolism
KW  - Blood Pressure
KW  - Body Weight
KW  - drug effects
KW  - Cardiovascular Diseases
KW  - etiology
KW  - Diabetes Mellitus, Type 2
KW  - blood
KW  - Diabetic Angiopathies
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - Exenatide
KW  - Female
KW  - Glycated Hemoglobin
KW  - Humans
KW  - Hypoglycemic Agents
KW  - adverse effects
KW  - Lipids
KW  - Male
KW  - Metformin
KW  - therapeutic use
KW  - Middle Aged
KW  - Overweight
KW  - Peptides
KW  - Risk Factors
KW  - Sulfonylurea Compounds
KW  - Venoms
KW  - Weight Loss
N1  - Publication Type: Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1111/j.1463-1326.2006.00602.x
ER  -